| 000 | 01877 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516150119.0 | ||
| 264 | 0 | _c20141112 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a1432-2072 | ||
| 024 | 7 |
_a10.1007/s00213-013-3116-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJucaite, Aurelija | |
| 245 | 0 | 0 |
_aA randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder. _h[electronic resource] |
| 260 |
_bPsychopharmacology _cMar 2014 |
||
| 300 |
_a1251-65 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAttention Deficit Disorder with Hyperactivity _xblood |
| 650 | 0 | 4 |
_aBridged Bicyclo Compounds, Heterocyclic _xadverse effects |
| 650 | 0 | 4 |
_aCognition _xdrug effects |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeuropsychological Tests |
| 650 | 0 | 4 |
_aNicotinic Agonists _xadverse effects |
| 650 | 0 | 4 | _aPsychiatric Status Rating Scales |
| 650 | 0 | 4 |
_aReceptors, Nicotinic _xmetabolism |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTobacco Use Disorder _xblood |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aÖhd, John | |
| 700 | 1 | _aPotter, Alexandra S | |
| 700 | 1 | _aJaeger, Judith | |
| 700 | 1 | _aKarlsson, Pär | |
| 700 | 1 | _aHannesdottir, Kristin | |
| 700 | 1 | _aBoström, Emma | |
| 700 | 1 | _aNewhouse, Paul A | |
| 700 | 1 | _aPaulsson, Björn | |
| 773 | 0 |
_tPsychopharmacology _gvol. 231 _gno. 6 _gp. 1251-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00213-013-3116-7 _zAvailable from publisher's website |
| 999 |
_c22720437 _d22720437 |
||